Pfizer seeks emergency authorization for COVID-19 booster in children ages 5 to 11

Pfizer-BioNTech submitted an application to the U.S. Food and Drug Administration Tuesday, for children ages 5 through 11-years-old to receive the COVID-19 vaccine booster, the company announced. In a statement, Pfizer said it submitted the application seeking approval under the Emergency Use Authorization after data from a study involving 4,500 children in the U.S., Finland, Poland, and Spain, seeking to determine the "safety, tolerability, and immunogenicity" of the vaccine produced a positive result.-- More...